Through enrichment analysis, we discovered that the signaling pathways in patients with favorable prognosis were associated with cancer immune response, while the group with poorer survival was correlated with oncogenic signaling, such as MAPK signaling pathway, PI3K-AKT-MTOR signaling, VEGF signaling pathway, ERBB signaling pathway, and so on. The gene discussed is MTOR; the disease is cancer.